Advance Search
TAN Haicheng, LIU Chang, LU Cong. Influences of saxagliptin on blood glucose spectrum of the patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (21): 128-130. DOI: 10.7619/jcmp.201321038
Citation: TAN Haicheng, LIU Chang, LU Cong. Influences of saxagliptin on blood glucose spectrum of the patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2013, (21): 128-130. DOI: 10.7619/jcmp.201321038
shu

Influences of saxagliptin on blood glucose spectrum of the patients with type 2 diabetes mellitus

More Information
  • Published Date: April 07, 2014
    Graphical Abstract
    • Abstract
    • FullText(HTML)
    • References (10)
  • Cook W, Bryzinski B, Slater J. Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors:Results of a pooled analysis of phase 3 clinical trials [J]. {H}Postgraduate Medicine, 2013(3):145.
    Schwartz S L. Treatment of elderly patients with type 2 diabetes mellitus:a systematic review of the benefits and risks of dipeptidyl peptidase-4 inhibitors [J]. Am J Geriatr Pharmacother, 2010(5):405.
    陆菊明. 2型糖尿病治疗新药沙格列汀的药理及临床评价 [J]. {H}中国新药杂志, 2011, (21):2039.
    Yang W, Lu J, Weng J. Prevalence of diabetes among menand women in China [J]. {H}New England Journal of Medicine, 2010, (12):1090.
    Hartman I, Rojas E, Rodríguez-Molina D. Incretin-based therapy for type 2 diabetes mellitus:pancreatic and extrapancreatic effects [J]. {H}American Journal of Therapeutics, 2013(4):384.
    Winkler G. Pleiotropic effects of incretins and antidiabetic drugs with incretine mechanism [J]. {H}Orvosi Hetilap, 2013(7):248.
    Stefansdottir G, Zoungas S, Chalmers J. Intensive glucose control and risk of cancer in patients with type 2 diabetes [J]. {H}DIABETOLOGIA, 2011(7):1608.
    McIntosh C H, Demuth H U, Pospisilik J A. Dipeptidyl peptidase Ⅳ inhibitors:how do they work as new antidiabetic agents [J]. {H}Regulatory Peptides, 2005(2):159.
    Ali S, Fonseca V. Saxagliptin overview:special focus on safety and adverse effects [J]. {H}Expert Opinion Drug Safety, 2013(1):103.
    Yoshioka K, Isotani H, Ohashi S. Efficacy of vildagliptin on glucose fluctuation in Japanese type 2 diabetic patients with ongoing sulfonylurea based oral glycemic agent therapy [J]. Diabetes Metab Syndr, 2013(1):32.
    • Related Articles

  • Related Articles

    [1]SU Jianpei, WANG Yongli, WANG Zhimin, WU Qi, GU Jun, LI Jin, LIANG Bijuan. Effects of dapagliflozin on inflammatory cytokines and cardiac function in elderly patients with preserved ejection fraction heart failure complicated with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2024, 28(7): 85-89,95. DOI: 10.7619/jcmp.20233206
    [2]SUN Mo, JIANG Zhihua, CHEN Shoutao. Effect of sitagliptin combined with rosiglitazone on glucose and lipid metabolism as well as insulin resistance in patients with type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2020, 24(14): 31-33. DOI: 10.7619/jcmp.202014008
    [3]WANG Zongling, DAI Lina, WANG Meixia, PAN Wen. Effects comparison of salatrine or glimepiride combined with insulin glargine on treatment of patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2018, (9): 31-35. DOI: 10.7619/jcmp.201809008
    [4]GONG Yi, YAN Xiaohong. Effect of pioglitazone on fasting blood glucose, postprandial 2 h blood sugar and glycated hemoglobintype in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2018, (5): 32-35. DOI: 10.7619/jcmp.201805010
    [5]XU Hui. Effects of metformin and gliclazide sustained-release tablets on blood glucose and blood lipid in patients with type 2 diabetes mellitus complicated with hyperlipidemia[J]. Journal of Clinical Medicine in Practice, 2018, (1): 42-44. DOI: 10.7619/jcmp.201801013
    [6]MA Yanhua, WANG Haidong. Self-management behavior of patients with type 2 diabetes mellitus and its effect on blood glucose control[J]. Journal of Clinical Medicine in Practice, 2017, (6): 52-54. DOI: 10.7619/jcmp.201706016
    [7]DUAN Junting, PENG Dingqiong, DONG Bin, LIU Feng, MAO Lili. Effect of sitagliptin plus melbine on blood glucose and incidence rate of cardiovascular events in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2016, (5): 18-21. DOI: 10.7619/jcmp.201605006
    [8]XIANG Min, CHENG Xinqin. Influence of detemir insulin combined with glimepiride and glargine insulin combined with glimepiride on blood glucose and body weight of patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2016, (3): 43-45. DOI: 10.7619/jcmp.201603013
    [9]WANG Feng. Influence of linagliptin on the blood glucose change in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2014, (13): 99-101. DOI: 10.7619/jcmp.201413033
    [10]CHEN Li. Efficacy and Security of dynamic glucose monitoring combined with continuous subcutaneous insulin infusion in treatment of patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2014, (1): 53-55. DOI: 10.7619/jcmp.201401016

  • Cited by

    Periodical cited type(9)

    1. 李易晨，柏承文. 免疫微生态肠内营养方案可改善重症急性胰腺炎患者肠道菌群和预后. 内科急危重症杂志. 2023(01): 26-29 .
    2. 江浩. 益生菌对重症急性胰腺炎患者免疫功能及血清TRF、PA、ALB、Hb水平的影响. 现代医学与健康研究电子杂志. 2021(03): 61-63 .
    3. 尚鸳鸳. 早期肠内营养支持对重症急性胰腺炎患者的临床疗效及安全性探讨. 临床医学工程. 2021(09): 1259-1260 .
    4. 薛静，李胜，谢文贤，秦健，缪婷，卢翠洁，王振，王浩. 益生菌联合早期肠内营养治疗重症急性胰腺炎临床疗效的Meta分析. 中国微生态学杂志. 2021(12): 1413-1419 .
    5. 廖健宏. 益生菌联合早期肠内营养对急性胰腺炎患者血浆白蛋白、C反应蛋白、淀粉酶及体质量等指标的影响研究. 现代消化及介入诊疗. 2020(03): 364-366 .
    6. 樊周沛，尹明明，李颖霞，温洪涛. 早期肠内营养对结肠癌患者术后康复进程和并发症的影响. 河南医学研究. 2020(18): 3300-3302 .
    7. 黄建，江钟立. 早期肠内营养重构肠道微生态促进缺血性脑卒中康复的研究. 现代消化及介入诊疗. 2019(04): 398-401 .
    8. 李明. 肠道微生态在急性胰腺炎发病和治疗中的应用研究进展. 世界最新医学信息文摘. 2019(58): 52-53 .
    9. 张紫盈，范正论. 早期肠内营养联合肠外营养对重症急性胰腺炎患者的临床研究. 临床医药文献电子杂志. 2019(94): 9 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML
    Article views (244) PDF downloads (6) Cited by(12)
    Turn off MathJax
    Article Contents
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return